ES413639A1 - Un procedimiento para la preparacion de un compuesto deri- vado de dopamina. - Google Patents
Un procedimiento para la preparacion de un compuesto deri- vado de dopamina.Info
- Publication number
- ES413639A1 ES413639A1 ES413639A ES413639A ES413639A1 ES 413639 A1 ES413639 A1 ES 413639A1 ES 413639 A ES413639 A ES 413639A ES 413639 A ES413639 A ES 413639A ES 413639 A1 ES413639 A1 ES 413639A1
- Authority
- ES
- Spain
- Prior art keywords
- hydrogen
- radicals
- methyl
- methoxy
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical class NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24346672A | 1972-04-12 | 1972-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES413639A1 true ES413639A1 (es) | 1976-01-16 |
Family
ID=22918877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES413639A Expired ES413639A1 (es) | 1972-04-12 | 1973-04-12 | Un procedimiento para la preparacion de un compuesto deri- vado de dopamina. |
Country Status (31)
| Country | Link |
|---|---|
| JP (2) | JPS5825656B2 (fr) |
| KR (1) | KR790000113B1 (fr) |
| AR (1) | AR203822A1 (fr) |
| AT (1) | AT323719B (fr) |
| AU (1) | AU472734B2 (fr) |
| BE (1) | BE798051A (fr) |
| BG (1) | BG23001A3 (fr) |
| CA (1) | CA1018188A (fr) |
| CH (2) | CH569691A5 (fr) |
| CS (2) | CS190406B2 (fr) |
| CY (1) | CY963A (fr) |
| DD (1) | DD107670B3 (fr) |
| DE (1) | DE2317710C2 (fr) |
| DK (1) | DK142750C (fr) |
| ES (1) | ES413639A1 (fr) |
| FR (1) | FR2182947B1 (fr) |
| GB (1) | GB1392674A (fr) |
| HK (1) | HK50178A (fr) |
| HU (2) | HU167597B (fr) |
| IE (1) | IE37511B1 (fr) |
| IL (1) | IL42016A (fr) |
| KE (1) | KE2870A (fr) |
| MY (1) | MY7800381A (fr) |
| NL (1) | NL174459C (fr) |
| PH (1) | PH11041A (fr) |
| PL (2) | PL90695B1 (fr) |
| RO (2) | RO65105A (fr) |
| SE (1) | SE399064B (fr) |
| SU (1) | SU496719A3 (fr) |
| YU (2) | YU36483B (fr) |
| ZA (1) | ZA732136B (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH585693A5 (fr) * | 1974-02-08 | 1977-03-15 | Ciba Geigy Ag | |
| US4342692A (en) * | 1980-10-20 | 1982-08-03 | Usv Pharmaceutical Corporation | Pyrrolidines |
| ZA825227B (en) * | 1981-07-22 | 1984-03-28 | Syntex Inc | Substituted pyrrolidine cardiovascular system regulators antihypertensives |
| JPS6061523A (ja) * | 1983-09-16 | 1985-04-09 | Shionogi & Co Ltd | 経口用ドブタミン製剤 |
| ZA881076B (en) * | 1987-02-24 | 1989-10-25 | Lilly Co Eli | Dobutamine salts |
| JPH0383364U (fr) * | 1989-12-18 | 1991-08-23 | ||
| AU658188B2 (en) * | 1991-05-20 | 1995-04-06 | Tsumura & Co. | Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient |
| ATE155125T1 (de) * | 1993-04-13 | 1997-07-15 | Duphar Int Res | Herstellung von dobutamin verbindungen |
| EP0620208B1 (fr) * | 1993-04-13 | 1997-07-09 | Duphar International Research B.V | Production de composés de la dobutamine |
| WO2004031129A2 (fr) | 2002-10-03 | 2004-04-15 | New Era Biotech, Ltd. | Nouveaux composes destines au traitement des maladies auto-immunes, des maladies immuno-allergiques et des rejets en cas de greffes d'organes ou de tissus |
| CA2560922C (fr) | 2004-03-26 | 2014-01-07 | New Era Biotech, Ltd. | Ameliorations apportees a des composes destines a etre utilises dans le traitement du sida ou d'autres maladies virales et infections associees au vih et compositions contenant ces composes, methodes de traitement de ces maladies et de ces infections et methodes de fabrication de ces composes et de ces compositions |
| GB0804213D0 (en) | 2008-03-06 | 2008-04-16 | New Era Biotech Ltd | A method of printing or preventing pain |
| US9192585B2 (en) | 2009-07-31 | 2015-11-24 | Cognition Therapeutics, Inc. | Inhibitors of cognitive decline |
| US8802734B2 (en) | 2009-09-09 | 2014-08-12 | Novaremed Limited | Method of treating or preventing pain |
| EP2747759A4 (fr) * | 2011-08-25 | 2015-05-13 | Cognition Therapeutics Inc | Compositions et méthodes pour le traitement de maladies neurodégénératives |
| AU2015210852B2 (en) | 2014-01-31 | 2019-01-24 | Cognition Therapeutics, Inc. | Isoindoline compositions and methods for treating neurodegenerative disease |
| DK3634394T3 (da) | 2017-05-15 | 2026-03-02 | Cognition Therapeutics Inc | Sammensætninger til behandling af neurogenerative sygdomme |
| CN114524734B (zh) * | 2021-12-27 | 2024-04-26 | 嘉实(湖南)医药科技有限公司 | 一种盐酸多巴酚丁胺的制备方法 |
| CN117326958B (zh) * | 2023-09-21 | 2025-07-11 | 锦州奥鸿药业有限责任公司 | 一种高纯度盐酸多巴酚丁胺的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2276619A (en) * | 1942-03-17 | N-phentlaliphatic-dihtoroxyphentnl |
-
1973
- 1973-03-28 ZA ZA732136A patent/ZA732136B/xx unknown
- 1973-04-09 GB GB1683573A patent/GB1392674A/en not_active Expired
- 1973-04-09 CY CY963A patent/CY963A/xx unknown
- 1973-04-09 DE DE2317710A patent/DE2317710C2/de not_active Expired
- 1973-04-10 FR FR7312845A patent/FR2182947B1/fr not_active Expired
- 1973-04-10 SE SE7305032A patent/SE399064B/xx unknown
- 1973-04-10 IE IE563/73A patent/IE37511B1/xx unknown
- 1973-04-11 SU SU1908277A patent/SU496719A3/ru active
- 1973-04-11 KR KR7300573A patent/KR790000113B1/ko not_active Expired
- 1973-04-11 AT AT318773A patent/AT323719B/de not_active IP Right Cessation
- 1973-04-11 DK DK196773A patent/DK142750C/da not_active IP Right Cessation
- 1973-04-11 CA CA168,428A patent/CA1018188A/en not_active Expired
- 1973-04-11 CH CH517473A patent/CH569691A5/xx not_active IP Right Cessation
- 1973-04-11 CH CH1112475A patent/CH580563A5/xx not_active IP Right Cessation
- 1973-04-11 BE BE1004956A patent/BE798051A/fr not_active IP Right Cessation
- 1973-04-11 AU AU54385/73A patent/AU472734B2/en not_active Expired
- 1973-04-11 YU YU00976/73A patent/YU36483B/xx unknown
- 1973-04-11 NL NLAANVRAGE7305097,A patent/NL174459C/xx not_active IP Right Cessation
- 1973-04-11 BG BG023268A patent/BG23001A3/xx unknown
- 1973-04-12 CS CS732601A patent/CS190406B2/cs unknown
- 1973-04-12 RO RO7374457A patent/RO65105A/fr unknown
- 1973-04-12 HU HUEI552A patent/HU167597B/hu unknown
- 1973-04-12 CS CS77171A patent/CS190448B2/cs unknown
- 1973-04-12 HU HUEI469A patent/HU166213B/hu unknown
- 1973-04-12 PL PL1973161874A patent/PL90695B1/pl unknown
- 1973-04-12 ES ES413639A patent/ES413639A1/es not_active Expired
- 1973-04-12 AR AR247523A patent/AR203822A1/es active
- 1973-04-12 IL IL42016A patent/IL42016A/en unknown
- 1973-04-12 DD DD73170118A patent/DD107670B3/de unknown
- 1973-04-12 RO RO7383749A patent/RO70892A/fr unknown
- 1973-04-12 PH PH14508A patent/PH11041A/en unknown
- 1973-04-12 PL PL1973183808A patent/PL94207B1/pl unknown
- 1973-04-12 JP JP48041750A patent/JPS5825656B2/ja not_active Expired
-
1978
- 1978-08-10 KE KE2870A patent/KE2870A/xx unknown
- 1978-09-07 HK HK501/78A patent/HK50178A/xx unknown
- 1978-12-30 MY MY381/78A patent/MY7800381A/xx unknown
-
1979
- 1979-12-28 YU YU3212/79A patent/YU37113B/xx unknown
-
1982
- 1982-08-27 JP JP57149025A patent/JPS58131945A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES387016A1 (es) | Un procedimiento para la preparacion de derivado de isoqui-nolina. | |
| ES439909A1 (es) | Procedimiento para la preparacion de derivados s-2-tiol-4,5-difeniloxazol. | |
| ES447664A1 (es) | Procedimiento de preparacion de derivados de cardenolidas. | |
| ES405479A1 (es) | Un procedimiento para la preparacion de derivados de benzo-diacepina. | |
| ES414956A1 (es) | Procedimiento para la preparacion de 4-(4-bifenilil)-buta- noles. | |
| ES378206A1 (es) | Procedimiento para la preparacion de nuevos 2-amino-5-ni- trotiazoles. | |
| ES418841A1 (es) | Procedimiento para la obtencion de derivados del acido pi- ridin-3-acetico. | |
| ES419386A1 (es) | Un procedimiento para la preparacion de nuevos derivados deindenopirrol. | |
| ES412068A1 (es) | Un procedimiento para la preparacion de compuestos anaste- sicos locales. | |
| ES364980A1 (es) | Un metodo para preparar nuevos derivados de adamantano. | |
| ES442612A1 (es) | Procedimiento para la obtencion de nuevos derivados de iso- quinoleina. | |
| ES461191A1 (es) | Un procedimiento para la preparacion de nuevos derivados de arilcarboxamida. | |
| ES417269A1 (es) | Procedimiento para preparar derivados de imidazolidinona. | |
| GB1108060A (en) | Indole derivatives and a process for their production | |
| ES405080A1 (es) | Procedimiento para la obtencion de derivados del carbinol. | |
| ES402551A1 (es) | Un procedimiento para la preparacion de derivados de pipe- razina. | |
| ES405281A1 (es) | Un procedimiento para preparar nuevos compuestos de cefa- losporina. | |
| ES410009A1 (es) | Un procedimiento para la preparacion de derivados de acidos7-acilamino-3-cefem-4-carboxilicos 3-sustituidos. | |
| ES409555A1 (es) | Un procedimiento para la obtencion de nuevos derivados de cefalosporina. | |
| ES366913A1 (es) | Un procedimiento para la preparacion de ciclohexanos susti-tuidos terapeuticamente activos. | |
| ES427622A1 (es) | Procedimiento para la preparacion de 2-amino-bencil-aminas. | |
| ES334733A1 (es) | Procedimiento para preparar derivados de esteres de acido-5halobenzoicos. | |
| ES379617A1 (es) | Procedimiento para la preparacion de aminoacidos. | |
| ES382191A1 (es) | Procedimiento para la preparacion de nuevos derivados de azepina. | |
| ES412886A1 (es) | Un procedimiento de preparacion de derivados de acidos tia-zolcarboxilicos. |